Cipher Pharmaceuticals
6560 Kennedy Road
Mississauga
Ontario
L5T 2X4
Canada
Tel: 905-565-0043
Fax: 905-565-1776
235 articles about Cipher Pharmaceuticals
-
Cipher Pharmaceuticals Annual and Special Meeting of Shareholders
4/13/2007
-
Cipher Pharmaceuticals Reports Fiscal 2006 Year-end Results
3/7/2007
-
Notice of Cipher Pharmaceuticals Conference Call
2/27/2007
-
Cipher Pharmaceuticals's Response To Approvable Letter For CIP-ISOTRETINOIN Accepted For Review By FDA
1/17/2007
-
Notice Of Cipher Pharmaceuticals Conference Call
10/26/2006
-
Cipher Pharmaceuticals Tramadol Fails Phase 3 Trial; Stock Tumbles 25%
9/11/2006
-
Cipher Pharmaceuticals Appoints New Chief Executive Officer
8/8/2006
-
Cipher Pharmaceuticals Reports 2006 Second Quarter Results
8/4/2006
-
Notice Of Cipher Pharmaceuticals Conference Call
7/26/2006
-
Cipher Pharmaceuticals Submits NDA For Once-Daily TRAMADOL Formulation
6/29/2006
-
Cipher Pharmaceuticals Appoints Vice President Of Scientific Affairs
6/23/2006
-
Cipher Pharmaceuticals Provides Update On Regulatory Path For CIP-TRAMADOL ER
6/15/2006
-
Cipher Pharmaceuticals Receives Health Canada Approval Of CIP-Fenofibrate
2/21/2006
-
Cipher Pharmaceuticals Provides CIP-Tramadol ER Update
1/27/2006
-
FDA Approves Cipher Pharmaceuticals Cholesterol Treatment
1/13/2006